What smart money is saying about Avon Technologies
1 fund in our archive has pitched Avon Technologies — most recently Liontrust UK Smaller Companies Fund in June 2026.
Avon Technologies Plc, together with its subsidiaries, provides respiratory and head protection products for the military and first responder markets in Europe and the United States. It operates through Avon Protection and Team Wendy segments. The company offers respirators, escape hoods, thermal imaging cameras, powered and supplied air, rebreathers, and underwater systems; spares and accessories, such as replacement filters, outserts, and communication systems; chemical, biological, radiological, and nuclear protective wear. It also provides ballistic and bump protection helmets; and liner and retention systems. The company offers its products under the Avon Protection and Team Wendy brands. In addition, it is involved in investment and pension fund trustee activities. Avon Technologies Plc was formerly known as Avon Protection plc and changed its name to Avon Technologies Plc in July 2024. Avon Technologies Plc was incorporated in 1890 and is based in Melksham, the United Kingdom.
Get an email when a fund buys, sells or pitches it
Position history
Every position in Avon Technologies on record in the archive was reported in Q2 2026, across 1 fund letter — 1 opened or added to the position.
| Quarter | Letters | Bought | Sold | Theses |
|---|---|---|---|---|
| Q2 2026 | 1 | 1 | 0 | 1 |
Fund activity · 1 position · 1 move
- New positionLiontrust UK Smaller Companies FundJune 2026
“With shares in the company trading within 1% of the offer price and not expected to complete for several months, we looked to redeploy the capital elsewhere. A new position was initiated in Avon Technologies, a designer and manufacturer of mission-critical personal protective equipment for armies, navies, law enforcement and first responders.”
Avon Technologies
Also mentioned · 1
These funds discuss Avon Technologies — as a competitor, benchmark or comparable — without disclosing a position in it.
- MentionedRoyal London UK Dividend Growth FundDecember 2025
“Performance commentary The fund lagged the benchmark but outperformed the peer group average over the quarter. The main detractor to performance was the healthcare sector, notably the underweight to AstraZeneca which performed strongly on improving sentiment in the US. Hikma Pharmaceuticals also detracted after a disappointing update in light of temporary production delays. Elsewhere, defence companies Chemring and Avon Technologies saw some selling pressure on talks of a potential ceasefire in Ukraine.”
Avon Technologies
Fund coverage · 1 thesis
- Liontrust UK Smaller Companies FundJune 2026
Avon Technologies makes mission-critical protective equipment and benefits from near-sole-source military contracts, high barriers to entry, and a management team focused on continuous improvement.
Read the full thesis
Read every full thesis on Avon Technologies
Unlock all 1 thesis — the full reasoning behind what funds are buying, plus unlimited access to the entire archive.
View plans→